Introduction
In mammalian cells, one of the most sensitive indicators of exposure to mutagenic carcinogens has been the induction of cytogenetic effects, chromosome aberrations and sister chromatid exchanges (SCEs). Some mutagens, such as ionizing radiations that induce double-strand breaks in DNA are very efficient at inducing chromosome aberrations and can induce them at all stages of the cell cycle. Some other physical mutagens, such as ultraviolet light, cannot induce breaks directly, but form lesions in DNA that lead to the production of chromatid aberrations later when the cells proceed to the S phase. Although a few chemical mutagens can induce double-strand breaks in DNA and thus are radiomimetic or X-raylike, the majority are like ultraviolet light in that they form lesions that are not converted to aberrations until the cells enter S. Unlike X-rays and the few radiomimetic chemicals, these S-dependent agents, be they physical or chemical, are genetic complement and can survive. This fact, coupled with the fact that the relation of the induction of aberrations to the dose of radiation is well understood, has made it possible to use the long-lived peripheral lymphocyte, which ordinarily does not divide, as a sensitive integrating biological dosimeter capable of making quantitative estimates of the absorbed dose in man. Because of the success with ionizing radiation, attempts have also been made to use the induction of cytogenetic effects to estimate the exposure to chemical agents. Here, however, we are on more tenuous grounds because most of the agents, being S-dependent, do not produce their effects immediately. During the interval between exposure and the formation of the cytogenetic effects, many factors can influence the final yield. Chief among these is the repair capacity of the cell, for only if the lesions remain in the DNA until the cells enter S will they retain their ability to lead to the types of errors of replication that produce chromatid aberrations or even SCEs.
If the exposure is to the unknown material that might be found in a chemical waste disposal site, many other problems exist. Now questions arise about what chemicals are in the mixture and in what proportions, whether the chemicals need metabolic activation, whether they act synergistically, additively or antagonistically, and whether they might be promoterlike or antipromoterlike. Furthermore, unlike the situation with ionizing radiation, in which the dosimetry is relatively straightforward, the dosimetric problems with chemicals are formidable, for neither their intracellular concentrations nor their biological half-lives are known with any certainty, and in cases of human exposure, questions also arise about the diffusibility of the chemicals and their transport to the cells in question. with high acute doses of some cytostatic agents. In this instance, the response is somewhat like that with relatively high doses of ionizing radiation (in the order of 10 rads). However, unlike radiationinduced chromosome aberrations, which are permanently formed shortly after exposure, SCEs are not formed in the Go lymphocyte, so that there is time for the damage to be repaired before the cell is stimulated to enter S. This leads to a decrease in SCE frequency with time after exposure, which adds another variable in the use of SCEs to monitor populations.
With some chemotherapeutic chemicals, however, it has been found, both in animals and humans, that after multiple exposures the lesions seem to last longer. As yet, it is not known if this persistence will occur after chronic exposures, nor is it known which classes of chemicals might be expected to produce long-lived lesions. Some chemicals, such as cyclophosphamide, can lead to lesions that last through several cell cycles, whereas others, such as N-acetoxyacetylaminofluorene, do not. Thus some potentially dangerous compounds might escape detection by this system.
In several attempts to monitor people exposed to suspected toxic Sister chromatid exchanges, which are much easier to score than chromosome aberrations, have provided our most sensitive cytogenetic laboratory test for S-dependent chemicals. They are also an efficacious way to determine exposure of people to high doses of these chemicals, but they are insensitive to S-independent agents such as ionizing radiations. Because of great interpersonal variability of response, variability in different reference populations, and the repair phenomenon just mentioned, it has not yet been proved that SCEs can be used to monitor populations for low-level chronic exposure. Much research and many surveys are needed before we will know whether or not the system will live up to our initial expectations.
It should also be noted that even when cytogenetic tests on peripheral lymphocytes show that the genetic material has been damaged, these tests can only be used to estimate risk in the population.
They cannot be used to predict that any given individual will suffer any particular form of ill health.
